Position in ANIP
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,042,456
-$213,162 QoQ
Shares Held
13,556
-14.8% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.61%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 11%
Shared 89%
None 0%
Common Shares in ANIP Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026VIRTUS ADVISERS, LLC holds $9,030,219 across 12 Drug Manufacturers - Specialty & Generic names. ANIP ranks #4 (11.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PAHC |
Phibro Animal Health Corp
|
41,542 | $2,297,687 | |
| 2 | ALKS |
Alkermes plc.
|
47,468 | $1,678,467 | |
| 3 | RDY |
Dr Reddys Laboratories Ltd
|
107,110 | $1,483,473 | |
| 4 | ANIP |
Ani Pharmaceuticals Inc
This page
|
13,556 | $1,042,456 | |
| 5 | PBH |
Prestige Consumer Healthcare Inc.
|
10,324 | $611,903 | |
| 6 | AMRX |
Amneal Pharmaceuticals, Inc.
|
35,921 | $446,498 | |
| 7 | AKBA |
Akebia Therapeutics, Inc.
|
308,000 | $428,120 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
2,584 | $340,416 |
All Filings in ANIP
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,042,456 | 13,556 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $1,255,618 | 15,906 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $1,456,989 | 15,906 | Shares | Other | 2026-02-13 | |
| 2025-06-30 | $1,037,865 | 15,906 | Shares | Other | 2026-02-13 | |
| 2025-03-31 | $921,967 | 13,771 | Shares | Other | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||